Risk of neutropenia among clozapine users and non-users: results from 5,847 patients

OBJECTIVE: Clozapine is underprescribed due to neutropenia risk. Blood tests every 3 months in those on continuous treatment for > 1 year who have never had an absolute neutrophil count (ANC) < 2,000/µL has been proposed as a monitoring strategy; however, there are no South American data to su...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldani, André Akira Sueno, Rabelo-da-Ponte, Francisco Diego, Feiten, Jacson Gabriel, Lobato, Maria Ines R., Belmonte-de-Abreu, Paulo S., Gama, Clarissa S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Psiquiatria 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827363/
https://www.ncbi.nlm.nih.gov/pubmed/34730717
http://dx.doi.org/10.1590/1516-4446-2021-1765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827363/
https://www.ncbi.nlm.nih.gov/pubmed/34730717
http://dx.doi.org/10.1590/1516-4446-2021-1765

Ejemplares similares